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Mitochondria are dynamic organelles with a morphology
controlled by fusion and ﬁssion events [1] that evolved from
endosymbiotic a-proteobacteria belonging to Rickettsia gender
[2]. They still present many similarities with prokaryotic cells such
as a double membrane, the ability to produce ATP through
the generation of a proton gradient generated across the inner
membrane or the fact that they have their own genome and
bacterial type ribosomes [2]. The bacterial origin of mitochondria is
further supported by the fact that various antibiotics, especially
bactericidal ones such as quinolones, aminoglycosides and b-
lactams are also able to induce mitochondrial dysfunction and
reactive oxygen species (ROS) production [3].
The mitochondrial DNA (mtDNA) encodes two ribosomal,
22 transfer RNA and only 13 peptides of the mitochondrial
proteins involved in the oxidative phosphorylation (OXPHOS)
system. Most of the mitochondrial proteome is thus encoded by
the nuclear genome [4].
Mitochondrial double membrane results in the formation of
four sub-compartments. Firstly, the outer mitochondrial mem-
brane (OMM) contains numerous porins that make it passively
permeable to small molecules (<5 kDa). Secondly, the inter-
membrane space (IMS) sequesters numerous of proteins acting as
damages-associated molecular patterns (DAMPs), such as cyto-
chrome c, endonuclease G, apoptosis-inducing factor (AIF), and
several pro-caspases, which are also recognised by pattern
recognition receptors (PRR) [5]. Indeed, their release in the cytosol
will induce inﬂammation and/or cell death. As subversion of
mitochondrial death pathways has already been extensively
reviewed [6], mechanisms related to apoptotic cell death will
not be developed in this review. Thirdly, the inner mitochondrial
membrane (IMM) contains the different complexes of the
respiratory electron transport chain (complexes I–IV) as well as
the Fo-F1 ATP synthase (complex V), which are responsible for ATP
production by the OXPHOS. This membrane is however much more
impermeable than the OMM. Furthermore, cardiolipin, a phospho-
lipid found exclusively in inner mitochondrial membrane and
bacterial plasma membrane, make the IMM less ﬂuid [7]. Conse-
quently, metabolites have to use a variety of selective transporters
to cross the inner membrane. The surface of this membrane forms
cristae to increase the ability to produce ATP in the matrix. In
addition, many mitochondrial proteins encoded by the nucleus
will need the import and sorting machinery present in both OMM
and IMM to reach the different sub-compartments [8]. According
to the compartment they reach, proteins will use different transport
complexes: translocase of the outer membrane (TOM)/translocase
of the inner membrane 23 (TIM23)/presequence translocase-
associated motor (PAM) for the matrix, TOM/TIM23 or TOM/
TIM22 for IMM, TOM/mitochondrial inter-membrane space assem-
bly (MIA) for IMS and TOM/sorting and assembly machinery (SAM)
for b-barrel proteins located in the OMM [8]. Finally, the matrix
contains multiple copies of mtDNA organised into nucleoids as well
as the machinery that is necessary to transcribe and translate
mtDNA-encoded genes. Reducing agents (NADH and FADH2) are
also generated in the matrix by the tricarboxylic acid (TCA) cycle and
the fatty acid b-oxidation (FAO) [9].
Even if mitochondria still share some features with its bacterial
ancestor, the organelle also acquired new characteristics such as a
dynamic morphology of the mitochondrial network that affects
both mitochondrial activity and function. According to cell types
and functional status, mitochondria can thus shift from separated
rounded/fragmented mitochondria into interconnected and elon-
gated tubular network [1]. This very dynamic organelle thus
continuously adapts the morphology and move to speciﬁc cellular
sub-compartments using different components of the cytoskeleton[1]. The mitochondrial morphology is determined by the balance
between two opposing processes that occur continually in the cell:
the mitochondrial ﬁssion and fusion that are mediated by large
GTPases related to the dynamin superfamily [10]. The fusion
occurs in two steps: ﬁrst the fusion of OMM mediated by the
homo-/heterodimerisation of mitofusin1/2 (MFN1/2) and then
optic atrophy 1 (OPA1) that forms homodimers leading to IMM
fusion. Fission process requires the recruitment of dynamin-
related protein 1 (DRP1) to the outer mitochondrial membrane,
where it will assemble to form a constriction ring leading to the
ﬁssion. Four different receptors for DRP1 located in the outer
membrane have been identiﬁed so far: mitochondrial ﬁssion 1
(FIS1), mitochondrial ﬁssion factor (MFF) and mitochondrial
dynamics protein of 49 and 51 kDa (MID49 and MID51) [1]. It is
important to note that mitochondrial morphology inﬂuences
the mitochondrial (dys)function while mitochondrial functional
status also controls the dynamics and shape of the organelle
[11]. Indeed, extremely depolarised and fragmented mitochondria
are degraded by mitophagy, a speciﬁc form of autophagy [1]. The
best-characterised mitophagy pathway involves the recruitment
of Parkin (an ubiquitin ligase) from the cytosol to the OMM by
PTEN-induced putative kinase 1 (PINK1). This relocation also
allows Parkin to poly-ubiquitinate proteins located in the OMM,
leading to their degradation by the 26S proteasome [12].
2. Mitochondrial targeting by bacteria
While the impact of the mitochondria functional status on the
efﬁciency and persistence of infection and/or trafﬁcking (for
intracellular bacteria) is still poorly understood, the effects of
bacteria infection on several parameters of the mitochondrial
population start to be better delineated.
First, to impact mitochondria, bacterial effectors need to cross
several barriers. They have ﬁrst to be secreted out of the different
layers of the bacterial envelope through dedicated secretion
systems, then to reach (and pass through) the host plasma and
organelle membranes. Several bacterial effectors, collectively
called AB toxin, once secreted in the extracellular medium, are
able to translocate inside the eukaryotic cell cytoplasm [13]. The B
domain is responsible for the cellular tropism and often induces
the receptor mediated-endocytosis [14] of the holotoxin followed
by the translocation of the A domain into the cytoplasm of the
targeted cell. The A domain has an activity responsible for
the ‘‘toxic effect’’ such as the glycosyl transferase activity of the
Clostridium difﬁcile toxin B (TcdB) [14] or the pore forming activity
of the Helicobacter pylori VacA toxin [15]. Moreover, in Gram-
negative bacteria, some complex secretion systems are able to
deliver effectors directly from the bacterial cytoplasm into host
cytoplasm [16] as observed for EspF of the enteropathogenic
Escherichia coli [6]. It is important to note that, to impact
mitochondria, effectors do not necessarily have to enter host
cells. Indeed, pore-forming toxins can induce mitochondrial
dysfunction and organelle fragmentation just by inducing ion
ﬂuxes through the plasma membrane (e.g. listeriolysin (LLO) of
Listeria monocytogenes [17]). Once in host cells, toxins that directly
target mitochondria have to enter and reach the appropriate
mitochondrial sub-compartment. They usually interact with
mitochondrial translocase complex to be imported (e.g. OMM:
Neisseria PorB [18], IMM: H. pylori VacA (vacuolating cytotoxin A)
[15] and mitochondrial matrix: enteropathogenic E. coli MAP
effector [19]).
As mitochondria evolved from an ancestral bacterium, some
similarities are observed between proteins containing mitochon-
drial targeting sequence (MTS) and sequences targeting to
bacterial cytoplasmic membrane such as the presence of a
cleavable hydrophobic domain containing non-conserved amino
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located at the N-terminal domain of the protein [20,21]. Further-
more, Neisseria PorB uses an evolutionary conserved ‘‘bacterial-
like’’ machinery to reach the OMM of infected cells. Indeed, the
SAM complex, the functional equivalent of b-barrel assembly
machinery located at outer membrane of gram-negative bacteria,
is composed of several subunits [18]. Even if the different subunits
are essential for the insertion of eukaryotic b-barrel protein into
the OMM, PorB insertion is exclusively dependent on the Sam50
subunit, the only subunit for which a bacterial homolog does exist
[18].
3. Energy metabolism
In mammalian cells, ATP is mainly produced from the
catabolism of glucose and fatty acids by co-regulated and
interconnected pathways that involves glycolysis and b-oxidation,
respectively, followed by TCA cycle and OXPHOS. After its entry in
the cell, glucose is phosphorylated by hexokinases forming
glucose-6-phosphate (G6P), which prevents the release from the
cell and allows its glycolytic degradation [22]. Glycolysis is a
cytosolic 10-reactions metabolic pathway leading to the conver-
sion of G6P into two molecules of pyruvate accompanied by the
production of two ATP and two NADH. The pyruvate is then
imported and converted in acetyl-CoA in the mitochondrial matrix,
where it will be fully oxidised into CO2 by TCA cycle, allowing
the formation of more reducing molecules such as NADH and
FADH2. Reducing agents, including those generated by FAO are
then oxidised, via the OXPHOS to generate a proton gradient cross
the IMM. The proton-motive force of this gradient will next be used
by the Fo-F1 ATP synthase (complex V) to produce ATP [22]. Besides
the production of ATP, mitochondria also contribute, at least partly,
to the biosynthesis of lipids [23], steroids, amino acids, nucleotides
and in the assembly of iron-sulphur clusters [24].
3.1. Mitochondrial metabolism and immune response
Unlike the paragraphs about mitochondrial ROS, calcium and
morphology described below in which we will develop examples
of direct manipulation of mitochondrial functions by bacterial
effectors, the present section about metabolism will only present
general and global impact of bacterial infection on cell metabolism,
that affect mitochondria. Some of the examples described might
thus refer to indirect effects of bacterial infection on mitochondria,
taking part in a broader metabolic reprogramming during cell
activation that might subsequently affect the organelle.
While the common pathway to produce energy from glucose in
mammalian cells includes the OXPHOS [22], in some conditions,
cells use preferentially and almost exclusively activated glycolysis
to produce ATP, even in the presence of oxygen, a condition that
coincides with a repression of the TCA cycle and the OXPHOS
[9]. This phenomenon, called aerobic glycolysis or Warburg effect,
was ﬁrst described in tumour cells in which it allows to supply
the anabolic demand associated with the high proliferation of
these cells [25]. Indeed, the partial glucose oxidation provides
precursors for the biosynthesis of carbohydrates, fatty acids and
amino acids as well as nucleotides and NADPH by the pentose
phosphate pathway (PPP), a pathway that also oxidises G6P
[26]. As the biosynthesis of new molecules consumes both
glycolysis and TCA cycle intermediates, anaplerotic reactions are
required to replenish those pathways. One of those reactions is
the glutaminolysis that consists in the degradation of glutamine
into a-ketoglutarate, an intermediate of the TCA cycle [9].
More recently, several studies have shown that the aerobic
glycolysis can contribute to different physiological processes such
as the maturation/differentiation and the activation of immunecells during infection, including a severe metabolic reprogram-
ming [22]. In fact, activated innate immune cells, including
neutrophils and dendritic cells (DCs), mostly rely on glycolysis and
glutaminolysis to produce their energy [22]. In neutrophils, this
metabolic shift from oxidative metabolism to glycolysis is under
the control of Toll-like receptor (TLR) induced hypoxia-inducible
factor 1 alpha (HIF-1a) [22]. It increases the production of NADPH
by the PPP, which is required to fuel the oxidative burst by NADPH
oxidase (NOX) system activated in response to microbial exposure
[22]. However, even if the mitochondrial respiration is not required
for cell ATP supply, the mitochondrial membrane potential is
involved in the temporal regulation of apoptosis induction
following neutrophil activation as the elimination of activated
neutrophils by this cell death pathway is crucial to prevent
unnecessary extended inﬂammation [27]. In DCs, the reprogram-
ming during activation is dependent on TLR-induced HIF-1a and
phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt/PKB)
pathway and seems to be required for the antigen presentation
and cytokine production [22]. This metabolic shift could also be
supported by a stronger recruitment of the glycolytic enzyme
hexokinase II (HKII) to the mitochondria [28].
Beside immune cell activation, metabolism is also involved in
cell differentiation and polarisation. Indeed, macrophages differ-
entiate from circulating monocytes once they inﬁltrate tissues.
Circulating monocytes, according to the environment they
encounter, are immunologically imprinted to tolerant (immuno-
suppression) or trained (innate immune memory which is antigen
unspeciﬁc) [29]. This imprinting will determine functional fate of
monocytes and macrophages, which is caused by a glycolytic
switch under the control of the activation of Akt/mammalian
target of rapamycin (mTOR)/HIF-1a pathway [30]. Macrophages
can display different phenotypes according their location and the
type of stimuli they respond to. The two best phenotypes
characterised are M1 and M2 macrophages [22]. The polarisation
M1 (classical activation) is induced in response to different pathogen
associated molecular pattern (PAMPs) such as lipopolysaccharide
(LPS) and interferon-gamma (IFNg). On the other hand, the M2
polarisation (alternative activation) is developed in response to
interleukins-4 and -13 (IL-4 and IL-13), two cytokines. M1
macrophages take part in the acute phase of inﬂammation and
are more efﬁcient to eliminate bacteria while M2 macrophages are
mainly involved in the resolution phase of inﬂammation and healing
process [31]. Classical macrophage activation in response to LPS
exposure is linked to the activation of glycolysis [32]. In addition, in
LPS-stimulated macrophages, glutaminolysis-derived a-ketogluta-
rate leads to the accumulation of succinate, which, once exported
from the mitochondria, is able to stabilise HIF-1a, the master
regulator of metabolic switch associated with macrophage classical
activation [32]. However, mitochondrial metabolism is also involved
in M1 macrophage functions as mtROS take part in their bactericidal
activity and pro-inﬂammatory cytokine secretion (see Section 4.1.1).
While M1 macrophages mainly rely on aerobic glycolysis to
acquire their bactericidal activity, M2 macrophage activation is
supported by FAO and mitochondrial oxidative metabolism. This
metabolic programme is regulated by signal transducer and
activator of transcription 6 (STAT6), a master regulator of Th2
polarisation in the immune response. This transcription factor
controls the expression of peroxisome proliferator-activated
receptors (PPARs) and PPAR gamma coactivator-1 beta (PGC-
1b), well-known regulators that promote mitochondrial biogene-
sis to sustain this activation [33].
Adaptive immune cells, undergo several phases after an
activating/challenge stimulus. Indeed, T lymphocytes, after their
activation by the DC-presented antigen recognition, will prolifer-
ate into clonal populations and then establish an antigen speciﬁc
memory [22]. At the basal state, CD4+ T-cells produce energy using
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[34]. When activated, they also switch from oxidative metabolism
to glycolysis and glutaminolysis. The glycolytic switch is also
induced in a PI3K/Akt-dependent pathway, in response to CD28
binding [35]. Additionally, T-cell receptor (TCR) binding, activates
extracellular signal regulated kinase (ERK)/mitogen-activated
protein kinase (MAPK) pathway, that in turn, induces glutamine
uptake and promote the expression of catabolic enzymes of
the glutaminolysis [36]. Metabolism might also play an important
role in the activation of CD4+ T-lymphocytes by controlling the
expression of key signalling molecules, such IL-2 and IFNg. The
mechanism would involve glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), one of the enzymes of the glycolysis, that binds
the 30-untranslated region (UTR) of IL-2 and IFNg mRNAs leading
to the inhibition of their translation. When glycolysis is activated in
T cells, GAPDH is required to promote the glycolytic ﬂux and,
consequently, is not able to bind these mRNAs anymore, allowing
the synthesis of IL-2 and IFNg by activated CD4+ T cells [37].
Memory T cells are also modulated by metabolism. For instance,
CD8+ T cells are able to enter in quiescent state to participate in
the memory response, allowing faster and stronger activation in
response to subsequent pathogen exposure. Unlike activated T
cells, memory T cells produce their energy by the mitochondrial
oxidative metabolism and especially by the FAO [38]. For example,
TNFa receptor-associated factor 6 (TRAF6) induces FAO and
mitochondrial biogenesis required for the establishment of a
memory response against L. monocytogenes and this process is
dependent on AMP-activated protein kinase (AMPK) signalling
[38]. The importance of metabolism for T-cells during bacterial
infection has recently and extensively been addressed [39].
This shift from oxidative metabolism to glycolysis observed
during immune cell activation seems to be a general response to
microbial exposure as it is also observed in various tissues such as
liver cells from infected mice exposed to the pathogenic bacteria
Salmonella enterica serovar typhimurium (S. typhimurium), lung
cells from Mycobacterium tuberculosis-infected mice, intestinal
epithelia from L. monocytogenes-infected mice and HepG2 cells
infected by Chlamydia pneumoniae. In all these models, it was also
shown that the metabolic reprogramming was under the control of
HIF-1a [9].
3.2. Manipulation of mitochondrial metabolism by bacterial
pathogens
Legionella pneumophila is known to secrete a mitochondrial
carrier protein during infection. This effector, targeted to the inner
mitochondrial membrane, is able to transport ATP from the matrix
to the IMS. However, the mechanism by which this effector
supports L. pneumophila infection still needs to be determined
[40]. As Eisenreich and collaborators have recently and extensively
reviewed the multiple facets by which metabolism could be
affected/manipulated by bacterial pathogens [9], we will focus in
the rest of the review on mitochondria-associated cell signalling
and mitochondrial messenger production affected by bacteria.
4. Mitochondria-associated cell signalling
4.1. mtROS and mitochondria
Mitochondrial respiration is responsible for the production of
mtROS as metabolic by-products. Indeed, mtROS are generated
through the monovalent reduction of a molecule of O2 by electrons
leaking from the mitochondrial electron transport chain (ETC) [41]
(Fig. 1A). mtROS abundance is however tightly regulated at two
different levels: their production and their degradation. First, the
quantity of mtROS produced depends on the mitochondrialrespiration rate. Indeed, an increase in mtROS production is
observed when the proton-motive force is enhanced [41]. Addi-
tionally, it has been suggested that uncoupling protein 2 (UCP2), a
ubiquitously expressed uncoupling protein, is involved in the
regulation of mtROS production [42,43] as, when activated, it
reduces the proton gradient across the IMM. However, it is not
clear whether UCP2 down-regulates mtROS production only
through its putative uncoupling activity or by the other mecha-
nism such as the regulation of the glutathione system [44].
mtROS degradation is also tightly regulated. Indeed, O2
() are
converted in H2O2 by superoxide dismutases (SODs). The three
members of this enzyme family display different locations in the
cell: SOD1 located in the mitochondrial IMS and cytosol, SOD2 in
the mitochondrial matrix and SOD3 is an extracellular form. H2O2
is then able to diffuse freely across the mitochondrial membrane to
reach to cytosol. In addition to SODs, there are other enzymes that
are able to detoxify H2O2: peroxyredoxins (PRXs), glutathione
peroxidases (GPXs) and catalase. On the one hand, GPXs are
thought to scavenge mtROS when found at high levels to prevent
damages in the organelle and keep the concentration of mtROS in
the range of concentrations that is compatible with ROS signalling
function. On the other hand, PRXs, which have a high substrate
afﬁnity and are highly expressed, are thought to be involved in the
termination of mtROS signalling that occurs at low concentrations
[41]. An important point that needs to be taken into account in the
modulation of mtROS signalling is the mitochondrial location
itself. Indeed, mtROS are short-lived molecules, so their efﬁciency
depends on the proximity between the site of production and the
site of targets [41].
In all of the studies mentioned in this review, it is assumed that
mtROS are only generated in response to bacteria exposure.
However, it is important to note that most of the studies referenced
below detected and/or quantiﬁed (mitochondrial) ROS content
using older technologies based on ﬂuorescent probes such as
dihydroethidium (DHE and MitoSox, its mitochondrial targeted
form) or dichlorodihydroﬂuoroscein (DCF) probes. These probes,
even if commonly used and accepted, present some disadvantages
(when compared to more recent methods) such as a lack of
speciﬁcity or even an artiﬁcial induction of ROS production when
too high concentrations are used as they can react with oxygen and
thus artiﬁcially elevate ROS abundance. In the future, studies to
analyse ROS in cells exposed to bacteria should opt for new
detection methods such as ﬂuorescent protein-based redox probes.
For additional information, Dikalov and Harrison recently
reviewed the advantages and limits of various old and recent
methods for ROS detection [45].
4.1.1. mtROS and immunity
4.1.1.1. mtROS and PRR. mtROS have been reported to be involved
in the clearance of different intracellular pathogens such as L.
monocytogenes, S. typhimurium or Toxoplasma gondii [43,46–
48]. During infection, mtROS production is induced in response
to PRR activation. PRR-induced signalling leads to the activation of
nuclear factor-kappa B (NFkB) and interferon regulatory factor
(IRF) pathways, that both promote the expression of pro-
inﬂammatory cytokines and chemokines as well as type I
interferon [49]. Those mediators are part of an arsenal required
for the development of an adequate immune response leading to
the eradication of pathogens [49]. PRR family contains three
different classes of receptors sensing different PAMPs/DAMPs
leading to the development of an effective immune response: TLR,
Rig-I like receptor (RLR) and NOD-like receptor (NRL) [49].
TLR are receptors located at the plasma membrane or at the
endosome/endoplasmic reticulum (ER) membranes that can sense
PAMPs associated with bacteria, viruses, fungi and parasites
Fig. 1. Mitochondria-associated redox signalling in host–pathogen relationship. (A) mtROS and immune response. mtROS (yellow stars) are produced as by-products of
mitochondrial respiration. They are involved in PRR regulation. (1) Activation of TLR1/2/4 leads to mtROS production in a TRAF6/ECSIT-dependent manner. These mtROS
participate to bacterial killing such as L. monocytogenes [46,47]. (2) mtROS promote RLR signalling by activating MAVS dependent pathway. MAVS signalling is primarily
involved in antiviral response (full arrow) but it can also take part in bacterial-induced interferon-b production (e.g. during L. pneumophila infection) (dotted arrow) [53,56].
(3) NLRX1 is able to promote mtROS production [120] while mtROS can induce NRLP3 [58]. mtROS can also modulate cytokine signalling (4) by inducing their transcription
[69,70], (5) by modulating their receptor availability [71] or (6) by taking part to the cytokine-induced effect [46]. Green arrows: positive effect; red arrows: detrimental
effect. (B) Examples of bacterial pathogens manipulating mtROS production: M. tuberculosis [73], C. trachomatis [76], E. chaffeensis [84], P. aeruginosa [83], H. pylori [79], heat
killed E. coli [80] and ASD-associated microbiome [82]. The table summarises the bacterial specie, the effector involved, the target cell/tissue, the effector impact on host cell
and the ﬁnal phenotype observed. Abbreviations: ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), FAO (fatty acid b-oxidation), IFNg (interferon gamma),
IL-1b/2/6 (interleukin-1b/2/6), MAVS (mitochondrial antiviral signalling protein), MCP1 (monocyte chemoattractant protein-1), mtROS (mitochondria reactive oxygen species), NLR
(NOD-like receptor), OXPHOS (oxidative phosphorylation), PGC-1b (peroxisome proliferator-activated receptor gamma coactivator 1-beta), STING (stimulator of interferon genes),
TACE (TNFa converting enzyme), TCA (tricarboxylic acid), TLR (Toll-like receptor), TNFR (TNFa receptor) and TRAF6 (TNF receptor-associated factor 6).
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regulated through cell signalling dependent on Jun N-terminal
kinase (JNK)/p38 pathways, promoting mtROS production fol-
lowed by a subsequent MAPK activation and the onset of
respiratory burst [43]. More recently, it was shown that, in
RAW264.7 macrophages, TLR signalling is able to trigger the
mtROS production and the recruitment of mitochondria around
the phagosome [47]. Indeed, in response to TLR1/2/4 binding,
TRAF6 is translocated at the mitochondria where it interacts with
evolutionarily conserved signalling intermediate in Toll pathways
(ECSIT), a protein that contributes to the ETC complex assembly.
TRAF6 interaction with ECSIT then promotes its accumulation at
the mitochondrial surface, triggering an increase in mtROS
production [47] (Fig. 1A).
It is important to note that while TLRs induce pro-inﬂammatory
responses in order to eradicate invading pathogens, they also take
part in resolution of this inﬂammation/oxidative stress as in order
to maintain mitochondria integrity and to prevent cell death, host
cells are able to respond by the activation of a transcriptionalprogramme leading to the expression of genes involved in anti-
inﬂammatory and anti-oxidant responses such as IL-10 and heme
oxygenase-1 (HO-1), respectively. This process is accompanied by
a stimulation of mitochondria biogenesis [50]. For example, a LPS-
mediated TLR4 challenge might also lead to the development of a
cell response aiming to recover from energy impairment [51]. It is
known that, in macrophages, the early effect of a LPS stimulation of
TLR4 is mitochondrial dysfunction, which, if prolonged, can be
detrimental for the host cell. TLR4, by its interaction with myeloid
differentiation primary responses gene 88 (MyD88) and TIR-
domain-containing adapter-inducing interferon-b (TRIF), is able
to activate the pro-survival PI3K/Akt pathway leading to the
expression of the mitochondrial transcription factor A (TFAM). This
signalling pathway leads, in ﬁne, to an increase in the abundance and
activity of two different subunits of the respiratory chain complex
IV, cytochrome oxidase-1 and -4 (COX1 and COX4), encoded by the
mitochondrial and nuclear genomes, respectively [51].
Alternatively, mtROS can also regulate TLR signalling. For
example, nuclear factor of activated T-cells 5 (NFAT5) is a
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as LPS-induced TLR4 signalling or NaCl induced-osmotic shock
[52]. A recent study showed that these stimuli lead to a ROS-
dependent expression inhibition of a subset of NFAT5 target genes
[52]. In addition, these authors have shown that ROS origin seems
to be crucial to qualitatively select genes regulated by this factor
as cytosolic ROS (generated by the xanthine oxidase) will promote
a pro-inﬂammatory response (IL-6 transcription) while mtROS
induce hypertonic response [52].
RLR are cytoplasmic receptors binding mostly virus-associated
PAMPs such as double stranded RNA [49]. Mitochondria are also
known to provide a platform for signalling induced by two
different RLR: RIG-I and melanoma differentiation-associated
gene-5 (MDA-5). RIG-I or MDA5 has been shown to signal through
mitochondrial antiviral signalling protein (MAVS), a nuclear
encoded protein located in OMM [53]. When activated, MAVS
interacts with stimulator of interferon genes (STING) located in
the ER membrane and TRAF3/6 leading to IRF3/7 and NFkB
activation [49].
The expression of RLR might also be regulated and controlled
by mtROS; cells deﬁcient for autophagy protein-5 (ATG5/ cells),
that contain high mtROS concentrations, up-regulate RLR expres-
sion as well as active signalling and are also more resistant to viral
infection [54] (Fig. 1A). However, mtROS are not the only
mitochondrial feature to regulate MAVS pathways. Indeed,
mitochondrial dynamics and membrane potential are also
required for efﬁcient MAVS signalling [53]. Furthermore, different
mitochondrial proteins have been reported to act as activators
such as TOM70 or inhibitors such as mitochondrial E3 ubiquitin
protein ligase 1 (MUL1) of MAVS signalling [53].
Interestingly, the mitochondrial protein ECSIT is not only
involved in the regulation of TLR signalling as it also participates in
RLR induced signalling. In fact, it has been shown that tripartite
motif 59 (TRIM59) is able to inhibit RLR-induced IRF and NFkB
activation by its interaction with ECSIT [55]. While type I interferon
is typically considered as an antiviral cytokine [56], it has been
shown that the gene encoding this cytokine is also induced in
response to bacterial infection [56]. For example, it has been shown
that RIG-I/MDA-5/MAVS pathway is involved in the induction of
IFNb in response to L. pneumophila, a facultative intracellular
bacterium (Fig. 1A). Furthermore, authors showed that SdhA, a
bacterial effector translocated in host macrophages during L.
pneumophila infection, is able to inhibit the IFNb production
probably by inhibiting the MAVS protein [56].
NLR is the third type of PRRs. In response to the detection of
cytosolic PAMPs/DAMPs, NLRs can induce a caspase 1-dependent
maturation of pro-inﬂammatory cytokines such as IL-1b and IL-18
[49]. The most-described family member is NLRP3 and recent
studies showed that mitochondria play a crucial role in the
activation of NLRP3 inﬂammasome by both the production of
mtROS (Fig. 1A) and the mtDNA release out of the organelle
[57,58]. NLPR3 activation requires the combination of two
different signals. The priming signal, coming from TLR4 and
cytokines receptors, that either induces NLRP3 transcriptional up-
regulation [59] and/or NLRP3 deubiquitination, in a mtROS-
dependent manner [60]. The second signal, which leads the
oligomerisation, can be triggered by different PAMPs and DAMPs,
including extracellular ATP, lysosomal destabilisation, (mt)ROS,
oxidised mtDNA and pore forming toxins-induced ions ﬂuxes such
as K+ efﬂux, a mechanism used by several bacteria such as L.
monocytogenes or Staphylococcus aureus to activate NLRP3 inﬂam-
masome [61]. The molecular mechanisms by which those different
signals activate NLRP3 are still poorly understood [61]. However,
NLRP3 activation seems to depend on a NLRP3 translocation
from ER to mitochondria, in a MAVS-dependent manner [62]
[58]. In macrophages, mitochondrial dysfunction caused by NLRP3inducers (such as nigericin and monosodium urate) leads to a
decrease in NAD+ concentration, which in turn leads to a decrease
in sirtuin2 (SIRT2), a NAD+-dependent deacetylase, activity leading
to the accumulation of acetylated a-tubulin that takes part in
dynein-dependent mitochondrial transport by microtubules
[63]. These authors suggest that cytoskeleton-dependent transport
of mitochondria would promote NLRP3 activation by apposing
mitochondrial apoptosis-associated speck-like protein containing
a CARD (ASC) and NLRP3 (on the ER) [63]. No matter what the
molecular mechanism of activation is, it seems that mitochondrial
dysfunction-mediated NLRP3 activation is also required to control
the infection of several facultative or obligate intracellular bacteria
such as Brucella abortus [64] or C. pneumoniae [65]. Interestingly,
some bacterial pathogens are also able to modulate NRL activation
as it is known that NRLP3 can be inhibited by toxins secreted by
several bacteria such as Yersinia enterocolitica (YopE and YopT),
Yersinia pseudotuberculosis (YopK), M. tuberculosis (Zmp1) and
Streptococcus pneumoniae (pneumolysin). These toxins can either
block inﬂammasome oligomerisation, prevent ligand to be
recognised or modulate NFkB/MAPK signalling to impair IL-1b
expression and activation [66].
Finally, bacteria activate other inﬂammasome such as absent in
melanoma-2 (AIM2) inﬂammasome, which recognise cytosolic
double stranded DNA. It has recently been shown that mtROS
might potentiate indirect activation of AIM2 inﬂammasome in
response to Francisella infection [67]. These authors showed that
mtROS might be involved in the regulation of AIM2 activation by
promoting bacterial DNA release. Indeed, Francisella novicida (a
non-virulent strain) is susceptible to mtROS induced-membrane
damages, while Francisella tularensis (a pathogenic strain) is not,
leading to a differential DNA release in the cytosol and a
differential AIM2 activation [67].
4.1.1.2. mtROS induction during infection. As mtROS production in
response to infections is dependent on respiration, different
strategies can be developed to increase the respiratory ﬂow: (1)
promoting the mitochondrial biogenesis and (2) enhancing
OXPHOS activity through FAO fuelling. Indeed, those hypotheses
were veriﬁed in infection models. First, in IFNg-stimulated
macrophages, the activation of oestrogen-related receptor alpha
(ERRa) and PGC-1b, two key regulators of mitochondria biogene-
sis [50], leads to an increase in the expression of several OXPHOS
components [46]. Second, a recent study on S. typhimurium
infection suggests that mtROS production in response to bacterial
infection depends on FAO [68]. Indeed, the activation of
glucocorticoid receptor and the stimulation of Janus kinase
(JAK)/STAT signalling pathway promote a CCAAT enhancer binding
protein (CEB/P) and STAT3-dependent transcription of immuno
responsive gene-1 (Irg1) encoding a mitochondrial protein that
regulates the mitochondrial uptake and FAO, and is required (but
not sufﬁcient) for mtROS production by murine macrophages in
response to S. typhimurium infection [68].
4.1.1.3. mtROS and cytokine signalling. mtROS are known as
modulators of cytokine signalling involved in immunity, as
demonstrated in various models [41]. The ﬁrst level of regulation
is the modulation of cytokine synthesis. Indeed, an increase in
mtROS abundance is observed in the spleen of L. monocytogenes-
infected mice invalidated for UCP-2 (Ucp-2/ mice), a phenome-
non that is accompanied with both an increase in expression of
pro-inﬂammatory cytokines such as IFNg, IL-6, IL-1b and
monocyte chemotactic protein-1 (MCP1) and a delay of infected
animal death [69] (Fig. 1A). Additionally, in T lymphocytes
activation, mtROS generated in response to TCR-mediated Ca2+
inﬂux, allow the activation of the transcription factor NFAT and
subsequent IL-2 production [70]. Secondly, mtROS are not only
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signalling efﬁciency by indirectly limiting the availability of their
receptor. For example, TNF receptor-1 (TNFR1) binding leads to a
Ca2+-dependent mtROS production [71]. Subsequently, mtROS are
able to activate the protease TNF-a converting enzyme (TACE)
leading to the receptor shedding which limits further or prevent
uncontrolled inﬂammation [71] (Fig. 1A). Finally, mtROS can also
take part in the cytokine-induced downstream signalling as it has
been shown, in L. monocytogenes infected-macrophages, that
bactericidal effect of IFNg is dependent on PGC-1b/ERRa induced
mtROS [46] (Fig. 1A). The importance of mtROS in the regulation of
a proper immune response signalling was recently supported by
the observation that splenocytes, isolated from Ucp-2/mice, that
contain high mtROS concentrations, failed to produce immuno-
globulin G (IgG) in response to LPS stimulation both in vitro and
in vivo [72].
In summary, it seems that ROS can participate to the immune
response in different ways: ROS can induce bacterial damages
leading to antimicrobial activity or are able to modulate infected
eukaryote cell signalling.
4.1.2. Modulation of redox signalling by bacteria
Considering the deleterious effects of ROS for bacteria in
infected cells, it not surprising that several bacteria developed
strategies to limit their production. For example, M. tuberculosis is
known to decrease ROS production by the N-acetyltransferase
activity of the effector enhanced intracellular survival (Eis).
Indeed, when cells are infected with mutant Mycobacteria that do
not express Eis, an increase in JNK dependent-ROS production
accompanied by the stimulation of autophagy and an inﬂamma-
tory response is observed [73]. It seems that Eis down-regulates
the LPS-mediated phosphorylation of JNK by acetylating
and activating MAPK phosphatase-7 (MKP7), a JNK-speciﬁc
phosphatase [74] (Fig. 1B).
If ROS are primarily a host defence mechanism, they can also be
detrimental for the host cells. The ROS dual effect in infected cells is
well illustrated in M. tuberculosis-infected macrophages. Indeed,
tumour necrosis factor alpha (TNFa) binding to its receptor
triggers mtROS production, which initially take part in bactericidal
activity [75]. However, in this model, mtROS will rapidly induce
necrosis, which results in bacterial release in the permissive
extracellular environment [75]. Some bacteria even manipulate
host cell to promote mtROS production. Indeed, Chlamydia
trachomatis, an intracellular bacterium responsible for a severe
sexually transmissible disease, induces ROS production to promote
its growth [76]. Indeed, once inside the epithelial cell, the bacteria
secrete effectors into the cytoplasm through the type 3 secretion
system (T3SS), which leads to a potassium exit from the cytoplasm.
This potassium efﬂux leads to ROS production by the NOX system,
which in turns, diffuse to the mitochondrial matrix and activate
NLRX1 to produce more ROS in the form of mtROS [76] (Fig. 1B).
ROS induction in C. trachomatis infected cells takes part in the
activation of caspase-1 by the NLRP3 inﬂammasome, a process
required for its intracellular growth [76,77].
mtROS can also directly cause the symptoms associated with
the disease. For example, during H. pylori infection, redox
signalling takes part in the inﬂammation and oncogenesis of the
gastric mucosae observed in patients [78], a phenotype that could
be explained by the mtROS production triggered by the pathogen
and its ability to inhibit DNA repair machinery causing nuclear and
mitochondrial genomic instability [78] (Fig. 1B). Indeed, mtDNA,
even in the nucleoid organisation, is particularly sensitive to this
genomic instability considering its proximity to the site of mtROS
production and the absence of histone complexes [79]. TLR4
dependent mtROS accumulation also mediates mtDNA damages as
observed in heat killed E. coli injected mice [80] (Fig. 1B).One can also mention that pathogenic bacteria are not the only
ones to induce mtROS production. Indeed, fermentation products
of the commensal gut microbiome, such as short chain fatty acids
(SCFA), are also known to induce mtROS production [81]. It is
interesting to note that propionic acid (PPA) overproduction, a
metabolic product of bacterial fermentation from commensal
bacteria of patients with ASD (Autism Spectrum Disorders) such as
Clostridia, Bacteriodetes and Desulfovibrio might also be involved in
the induction of mitochondrial dysfunction observed in patient gut
and brain [82]. PPA is a low molecular weight organic acid that can
accumulate in the cytosol causing intracellular acidiﬁcation and
subsequent carnitine dependent-mitochondrial dysfunction that
impairs fatty acid metabolism [82] (Fig. 1B).
As mentioned previously, regulation of ROS content occurs at
two different levels: their production and their scavenging/
detoxiﬁcation rate. Hereafter are two examples of bacteria whose
virulence is dependent on the modulation ROS content by
interfering with their detoxiﬁcation. Firstly, most of bacteria
possess their own ROS detoxiﬁcation enzymes. However, it was
unclear if those enzymes take part in the bacterial virulence during
infection. A recent study analysed the potential implication LsfA, a
1-cys PRX of the opportunistic pathogen Pseudomonas aeruginosa
during infection. It was shown that LsfA is involved in the bacterial
resistance to NOX burst occurring in infected macrophages
[83]. Even if no data are available about the impact of those
enzymes on mitochondrial ROS, it is reasonable to think that they
might be involved in their detoxiﬁcation as well as it appears that
the mtROS participate to bacterial killing in infected macrophages
[84] (Fig. 1B). It would thus be interesting to study the impact of
those bacterial enzymes on the mitochondrial ROS cytotoxicity.
Secondly, it is crucial for some bacteria to prevent programme cell
death of their host cell. For example, Ehrlichia chaffeensis secretes a
mitochondrial-targeted effector during monocyte/macrophage
infection. This bacterial toxin seems to up-regulate the mitochon-
drial detoxiﬁcation enzyme MnSOD/SOD2, which results in a lower
ROS content and an inhibition of apoptosis [84] (Fig. 1B). However,
a more systematic analysis and screen of the different antioxidant
enzymes would be necessary to address the origin and mecha-
nisms leading to the altered ROS production in response to
bacterial pathogens.
4.2. Calcium signalling and mitochondria
Free calcium bivalent cation is a key signalling molecule in
eukaryotic cells. In basal state, cytosolic and mitochondrial
calcium concentrations ([Ca2+]c; [Ca2+]mt, respectively) are very
low (ranging between 100 and 200 nM) when compared with
millimolar concentration found in the extracellular ﬂuids [85]
(Fig. 2A). This gradient concentration is maintained by the action of
several ligand and/or voltage-dependent channels (uniporters and
antiporters) and ATP-consuming pumps for calcium located in the
plasma membrane and membranes of organelles such as mainly
the ER and mitochondria [86]. In response to various stimuli,
channels located in the plasma membrane or the ER membrane
do open, allowing calcium (in)ﬂuxes or release, that leads to a
sudden (and often transient) 10-fold increase in the cytosolic
calcium concentration (>1 mM) (Fig. 2A). These changes in calcium
concentration can be translated into different cell responses such
as muscle contraction or vesicle secretion depending on cell type
and conditions [85]. Even if the major intracellular calcium store is
the ER (a calcium reservoir in which calcium concentration reaches
0.5 mM), mitochondria also cycle and/or accumulate calcium in
the matrix [86] (Fig. 2A). In conclusion, mitochondria regulate
calcium signalling by taking and releasing Ca2+ locally, allowing
changes in concentration in microdomains [86]. Indeed, when
calcium concentration increases in the cytosol, calcium also
Fig. 2. Mitochondria-associated calcium signalling in host–pathogen relationship. (A) Mitochondrial calcium regulation: The very low basal cytosolic calcium concentration is
maintained by the action of several channels and ATPases pumps located either at the plasma, ER and mitochondrial membranes. Calcium release from the mitochondrial
matrix is mediated by sodium exchange from the IMM to the matrix, which in turns is exported from the matrix by the sodium/proton exchange (calcium ﬂuxes are shown in
blue). Changes in cytosolic calcium concentration can lead to the activation of signalling pathways. At moderate concentrations, calcium promotes several mitochondrial
functions (green arrows) such as TCA cycle, OXPHOS (and subsequent mtROS production (yellow stars)), FAO, glutaminolysis, and urea cycle [89]. However, at high
concentrations, calcium induces mitochondrial dysfunction (red arrows), PTP opening and cell death [89]. (B) Examples of immune functions modulated by calcium
signalling: macrophage phagocytosis [92], neutrophils chemotaxis [93], lymphocytes activation [95] and antigen processing and presentation by APCs [94]. (C) Examples of
bacterial pathogens modulating calcium signalling: Group A Streptococcus [98], C. difﬁcile [101], H. pylori [99,102], C. septicum [100], L. monocytogenes [102] and Shigella
[103]. The table summarises the bacterial specie, the effector involved, the target cell/tissue, the effector impact on host cell and the ﬁnal phenotype observed. Abbreviations:
A/A (ammonia/ammonium), APC (antigen presenting cell), FAO (fatty acid b-oxidation), IP3R (inositol-3-phosphate receptor), MCU (mitochondrial calcium uniporter), OXPHOS
(oxidative phosphorylation), PTP (permeability transition pore), SERCA (sarco/endoplasmic reticulum calcium ATPase), SLO (streptolysin O), TCA (tricarboxylic acid), TcdB
(Clostridium difﬁcile Toxin B), VacA (vacuolating cytotoxin A) and VDAC (voltage-dependent anion channel).
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reach the mitochondrial matrix, cytosolic calcium has to cross both
mitochondrial membranes. The ions cross the OMM by the protein
voltage-dependent anion channel-1 (VDAC1) also known as the
mitochondrial porin that functions as a gatekeeper for the entry
and exit of mitochondrial metabolites) and the IMM by the
recently identiﬁed mitochondrial calcium uniporter (MCU), a
highly speciﬁc transporter [87] (Fig. 2A). In some conditions,
calcium export might be mediated by the PTP, even if this is still
controversial [88] but calcium efﬂux could also be mediated by the
exchange with sodium, which, in turn, is pumped outside of the
matrix by a sodium/proton exchange [89] (Fig. 2A).
Calcium homeostasis is not only regulated by mitochondrial
bioenergetics and redox status but also contributes to maintain
several functions in mitochondria (Fig. 2A). Calcium, ATP and
ROS concentrations are thus tightly interconnected and their
regulation involves several crosstalks [89]. Firstly, calcium entry in
the mitochondrial matrix is dependent on the mitochondrialmembrane potential. Secondly, calcium entry and accumulation
into the matrix can be modiﬁed by ROS [89] while its positive effect
on TCA and respiratory chain can modulate ROS formation
[89]. Mitochondrial activity is dependent on calcium concentration
as mitochondrial calcium stimulates the TCA cycle and OXPHOS
through positive allosteric regulation of 3 enzymes (pyruvate
dehydrogenase, isocitrate dehydrogenase and a-ketoglutarate
dehydrogenase) [89]. Calcium also stimulates enzymes belonging
to (Cytochrome c oxidase, Fo-F1 ATP synthase) or regulates
(glycerophosphate dehydrogenase and adenine nucleotide trans-
locase) the OXPHOS [89]. Moderate increase in [Ca2+]mt therefore
results in a higher ATP production [89]. However, calcium also
regulates mtROS production. Indeed, increased calcium not only
boosts the respiratory chain and thus the associated electron
leakage [90], but also might dissociate cytochrome c from the IMM
cardiolipin leading to an increase in electron leakage [89]. Calcium
also regulates other mitochondrial functions than bioenergetics
such as urea cycle [89] and the glutaminolysis [90].
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impact on different mitochondrial functions, sustained high
concentration of this ion is detrimental for mitochondria and
can induce mitochondrial dysfunction [89]. It is well described that
calcium overload leads to an increase in the IMM permeability
that can result to cell death [91].
4.2.1. Calcium signalling and immunity
Mitochondria associated calcium signalling is involved in the
regulation of the immune response. Calcium signalling promotes
Mycobacterium bovis phagocytosis and processing in macrophages
[92] (Fig. 2B). Secondly, mitochondrial UCP2 down-regulates the
polymorphonuclear neutrophils (PMN) chemotaxis by increasing
the [Ca2+]c also responsible for the increased expression of b2-
integrins allowing the initial ﬁrm adhesion of PMN to endothelial
cells [93] (Fig. 2B). Finally, calcium also regulates adaptive
immunity by promoting T lymphocytes activation by two
mechanisms [94]. On the one hand, calcium controls the antigen
processing and presentation in antigen presenting cells (APCs), a
step that is required to get T lymphocytes activated (Fig. 2B).
Indeed, it has been shown that the inhibition of Fo-F1 ATP synthase
and MCU, both inhibit the antigen processing [94]. On the other
hand, calcium can regulate T-cell activation itself. When exposed
to an appropriate stimulus, mitochondria relocate near the
immunological synapse to regulate the Ca2+ ﬂuxes and provide
local energy required for T-cell activation and cytokine secretion
[95,96] (Fig. 2B).
The importance of calcium signalling during intracellular
bacterial infection is now emerging. Interestingly, a recent
screening (using a library of 640 drugs targeting various host cell
functions (host-directed antimicrobial drugs)) devoted to test
drugs able to make THP-1 cells resistant to four different bacteria
(B. abortus, Coxiella burnetii, L. pneumophila and Rickettsia conorii)
revealed that most of these drugs target either G protein-coupled
receptors, membrane cholesterol distribution and intracellular
calcium signalling [97]. The fact that numerous drugs modulating
calcium signalling in infected cells were able to protect THP-1 cells
against four different bacteria species that display different
lifestyles emphasises the central role of calcium signalling during
bacterial infections. In the following paragraph, recent mecha-
nisms by which bacteria exert an impact on calcium homeostasis
and calcium signalling will be discussed.
4.2.2. Subversion of calcium homeostasis by bacteria
Bacterial pathogens can manipulate calcium signalling in
eukaryotic cells in order to modulate mitochondria-dependent
apoptosis. Group A Streptococcus (GAP), extracellular bacteria
found on oropharynx and damaged skin, have to reach deeper
tissues to cause infection [98]. The mechanism used by GAP to
achieve this goal is to secrete streptolysin O (SLO), a pore-forming
molecule that induces premature differentiation and apoptosis of
keratinocytes. Those pores increase the permeability of the plasma
membrane and allow calcium inﬂux in the cytosol, leading to ER
stress and mitochondrial dysfunction that subsequently triggers
apoptosis [98] (Fig. 2C).
H. pylori infection leads to gastric cell death caused by the
ammonia/ammonium (A/A) produced by the bacteria [99]. These
authors showed that A/A-associated cytotoxicity was mediated by
the activation of a N-methyl-D-aspartate receptor, which leads to
calcium entry. Cytosolic calcium is thus ﬁrst taken by the ER,
mediated by the sarco/endoplasmic reticulum calcium ATPase
(SERCA) pumps, and then transferred to mitochondria. Calcium
also induces the transcription of cell death effectors such as BAK
and BAX and activates calpain and cathepsin B, which both take
part in A/A cytotoxicity. The consequences of these changes result
in OMM damage, ATP depletion and ﬁnally cell death [99] (Fig. 2C).Clostridium septicum is a commensal gut bacterium that can
sporadically cause necrosis of the human skeletal muscle cells.
These bacteria secrete a-toxin in the extracellular environment
that inserts into myoblast plasma membrane, forms a Ca2+
permeable channel, and triggers a calcium inﬂux [100]. Subsequent
calpain activation and release of cathepsins from lysosomes then
modify cytoskeleton organisation. In these conditions, the increase
in cytosolic calcium concentration also leads to mitochondrial
dysfunction, a decrease in ATP production as well as nuclear DNA
damages, and other hallmarks of necrosis [100] (Fig. 2C).
C. difﬁcile is an extracellular bacterium responsible for pseudo-
membranous colitis. C. difﬁcile secretes toxins (TcdA and TcdB)
that will disrupt the epithelial barrier. A recent study showed that
TcdB seems to induce apoptosis in epithelial through the inhibition
of the mitochondrial ATP sensitive potassium channel, which
accompanied with an increase in [Ca2+]c, leads to mitochondrial
membrane hyper-polarisation and apoptosis [101] (Fig. 2C).
While severe and sustained changes in calcium concentration
in response to infection might lead, in ﬁne, to cell death, some
pathogens do subvert calcium signalling in a cell death-indepen-
dent manner. For example, in eosinophils exposed to puriﬁed
VacA, a pore forming toxin secreted by H. pylori, the toxin is able to
induce Ca2+ release from intracellular stores. This increase in
cytosolic calcium concentration leads to an increase in mtROS
production, subsequent NFkB activation and chemokine produc-
tion responsible for the recruitment of inﬂammatory cells in the
gastric mucosae observed in infected patients [102] (Fig. 2C).
Another illustration is given for LLO, a bacterial toxin secreted by
L. monocytogenes during infection, is able to oligomerise to form
pores in the plasma membrane of infected HeLa cells. The calcium
inﬂux and the metabolite leakage mediated by these pores induce
a transient membrane potential disruption, mitochondrial frag-
mentation, and a decrease in the ATP production. The mitochon-
drial fragmentation might thus induce a ‘‘transient metabolic
slow down’’ required for the establishment of the bacterial
replicative niche [17] (Fig. 2C). Eventually, Shigella is an
intracellular bacterium known to induce actin re-organisation
during infection. A recent study showed that such cytoskeleton
alterations limit the diffusion of small solutes and therefore lead
to conﬁnement of calcium signalling at bacterial entry sites
[103]. This microenvironment promotes a long-lasting calcium
signalling taking part in calcium dependent-protease activation,
known to be involved in Shigella infection. This calcium rich
environment also allows the induction ATP production required
for the actin re-organisation by mitochondria that are trapped in
the polymerised actin, while it prevents the spreading of
apoptotic signalling associated with sustained and largely
diffused high calcium concentrations at early stages of the
infection [103] (Fig. 2C).
4.3. mtDAMPs
As mentioned in Section 1, in addition to PAMPs, PRR also
recognise DAMPs, molecular patterns that are sequestered in
healthy tissues but exposed/released when cells are damaged, in
response to trauma or necrosis for instance [49]. As mitochondria
still display some prokaryote-related features, several mitochon-
drial components could be recognised as mitochondrial DAMPs
(mtDAMPs).
Firstly, mtDNA, which like the bacterial genome is enriched in
unmethylated CpGs [104] is able to activate TLR9 [105]. For
example, injection of endogenously oxidised mtDNA (but not
nuclear DNA) in mice leads to the development of arthritis in mice,
a phenotype that could be supported by the fact that oxidised
mtDNA induces NFkB-dependent TNFa production by monocytes/
macrophages [106]. In addition, mtDNA are able to stimulate
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ever, it seems that, according to cell type, unmethylated CpG-
oligodeoxynucleotide (CpG-ODN) is able to promote a pro- or anti-
inﬂammatory response [107]. In immune cells such as macro-
phages, a chaperone Unc93b1 is able to shuttle TLR9 from the ER to
the lysosomes, where receptor processing and binding by CpG-
ODN leads to the classical MyD88-dependent pro-inﬂammatory
response [107]. However, in non-immune cells, mitochondria take
part in the development of an anti-inﬂammatory response. While
in neurons and cardiomyocytes, Unc93b1 is less abundant and
TLR9 is mainly found in the ER [107]. Consequently, TLR9 binding
by CpG-ODN triggers a different signalling in those cell types.
Indeed, in the ER, TLR9 interacts with SERCA2 (a calcium ATPase
pump), decreases its activity limiting the calcium (re)entry in the
ER lumen and subsequently reduces the calcium transfer to the
mitochondria. A higher AMP/ATP ratio associated with lower
mitochondrial matrix calcium concentration also leads to AMPK
activation, a condition known to promote autophagy and cell
survival [107,108].
Secondly, similar to prokaryotes, mitochondrial translation is
initiated by the addition of N-formyl methionine [109]. Conse-
quently, mitochondrial N-formyl peptides can trigger inﬂamma-
tion. They are recognised by formyl peptide receptor-1 (FPR-1) in
PMN, which leads to their activation in a MAPK-dependent manner
[110]. The same group also recently showed that mtDAMPs are
able to promote PMN adherence to endothelial cells (EC) and
enhance systemic endothelium permeability [111]. Additionally,
other mitochondrial proteins, such as the mitochondrial transcrip-
tion factor TFAM are also able to act as mtDAMPs [112]. TFAM
release by necrotic cell potentiates cells to produce CXC chemokine
ligand-8 (CXCL-8) in response to N-formyl-peptide exposure
[112]. In addition, some mitochondrial proteins, such as heat
shock proteins of 60 and 70 kDa (HSP60 and HSP70) are still able to
trigger inﬂammation via TLR4 activation in macrophages, leading
to the production of IL-6 and TNFa, when they are released in the
blood stream for example after surgery [113,114]. Furthermore,
mitochondria extracts from H2O2-stressed THP-1 cells induce
stronger TLR4-dependent inﬂammatory response when compared
with mitochondrial extracts of control cells [115]. Eventually, very
recently, a study showed that in response to trauma induced-cell
injury, mtDAMPs released in the extracellular ﬂuids could activate
gd-T lymphocytes (assessed by an increase in TLR expression and
cytokines production), which are known to be involved in healing
processes [116].
As mentioned in Section 1, mitochondrial morphology and
functions are tightly related. It is thus not surprising that several
bacterial pathogens can alter mitochondrial morphology during
infection to manipulate mitochondrial functions.
5. Mitochondrial dynamics
In recent years, several bacterial effectors have been reported to
induce or inhibit mitochondrial fragmentation to control different
cell responses. While not exhaustive, here are few examples of
recently characterised effectors known to modulate mitochondrial
morphology during bacterial infection. First, as described in
Section 4.2.2, subversion of calcium homeostasis by bacteria
during infection, L. monocytogenes secretes a pore-forming toxin
called LLO. Pores formed at the plasma membrane by this bacterial
effector allow calcium inﬂux in the cytoplasm leading to
mitochondrial fragmentation [17]. These authors show that
alterations of mitochondrial morphology occur rapidly after (or
even before) bacterial entry, are transient and accompanied with
a decrease in ATP production. They also hypothesised that
mitochondrial fragmentation observed during L. monocytogenes
infection might mediate a ‘‘metabolic slow-down’’ required forthe establishment of the bacterial replication niche [17] but this
remains to be experimentally demonstrated. The mechanism
involved in the LLO-induced fragmentation is not clear as LLO
could induce an atypical ﬁssion mediated by a DRP1- and OPA1-
independent mechanism [117]. Secondly, VacA is also a pore-
forming toxin secreted during H. pylori infection that localises, at
least partially, at the mitochondria. VacA would induce activation
and recruitment of DRP1 resulting in mitochondrial fragmentation
in infected cells. DRP1-induced fragmentation also leads to BAX
activation, cytochrome c release and ﬁnally programmed cell
death [118]. The molecular mechanisms by which VacA induces
DRP1-mediated mitochondrial fragmentation and the connection
between mitochondrial fragmentation and BAX activation remain
to be determined [118]. Finally, Vibrio cholerae secretes VopE, a
T3SS-secreted effector, that inhibits mitochondrial network
reorganisation [119]. It was shown that in cells infected with V.
cholerae depleted for the gene encoding this effector, some T3SS-
associated components induce mitochondrial peri-nuclear clus-
tering that leads to MAVS aggregation and induction of NFkB
signalling. The mitochondrial clustering could be mediated by
Miro1 and Miro2 (two Rho GTPases) that sense calcium ﬂuxes
changes in response to V. cholerae infection. However, in cells
infected with the WT bacteria, VopE, which acts as a speciﬁc
GTPase activating protein (GAP), is able to physically and directly
interact with Miro1 and Miro2 keeping them in a GDP-bound form
allowing the inhibition of mitochondrial clustering and subse-
quent pro-inﬂammatory signalling. Thus, changes in mitochondri-
al morphology during V. cholerae infection seem to inhibit the
development of an efﬁcient immune response [119].
6. Perspectives
If the impact and effect of infectious pathogens on mitochondria
are relatively well studied, it is now imperative to assess the effect of
mitochondrial activity and metabolic status during infection.
Systematic studies to analyse the effect of boosted or impaired
mitochondrial functions on infection efﬁciency, intracellular traf-
ﬁcking (for facultative or obligate bacteria), bacterial resistance or
sensitivity to intra- and extracellular defence mechanisms should be
developed in the future to better understand the numerous and
tightly regulated cross talks between a host and its bacterial
pathogens. In addition, mechanisms by which bacteria affects,
directly or indirectly, mitochondria still need to be determined as
many bacterial effectors are still most likely to be identiﬁed.
Eventually, the origin of increased mtROS production detected in
response to bacterial infection still need to be addressed by modern
and robust approaches to detect ROS, especially that so far, few
elements allow to determine whether the changes in mtROS
abundance in response to bacterial pathogens result from a true
increase in their production or a reduction of antioxidant capacity.
7. Conclusion
As we have seen, mitochondria are very important organelle
allowing many functions in the immune systems, especially
through metabolic control, calcium homeostasis and mtROS
production and degradation [89]. Many of these mitochondrial
controls help the host to defend against the pathogens. However,
many bacteria (both intracellular and extracellular) have also
evolved and developed several types of effectors and mechanisms
that target and alter the mitochondria to circumvent or avoid
mitochondria-dependent mechanisms, such as mtROS production,
that could be deleterious or harmful for the pathogenic bacteria.
Finally, the expected outcome of future studies should bring a
better knowledge of effectors and mechanisms that affect
mitochondria as well as a detailed picture of the importance of
E. Lobet et al. / Biochemical Pharmacology 94 (2015) 173–185 183this organelle in infection, data that could also probably help to
identify new host mitochondrial targets and the development of
innovative medications to ﬁght bacterial pathogens.
Acknowledgements
Elodie Lobet is a doctoral Research Fellow at FRS-FNRS (Fonds
de la Recherche Scientiﬁque, Belgium). The authors thank Michel
Savels for his great contribution to the ﬁgure layout. This work was
supported by the Actions de Recherches Concerte´es-Communaute´
Franc¸aise de Belgique (Grant number Convention N8 08/13-015).
References
[1] Mishra P, Chan DC. Mitochondrial dynamics and inheritance during cell
division, development and disease. Nat Rev Mol Cell Biol 2014;15:634–46.
[2] Pallen MJ. Time to recognise that mitochondria are bacteria. Trends Microbiol
2011;19:58–64.
[3] Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S,
et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative
damage in mammalian cells. Sci Transl Med 2013;5:192ra85.
[4] Bonawitz ND, Clayton DA, Shadel GS. Initiation and beyond: multiple functions
of the human mitochondrial transcription machinery. Mol Cell 2006;24:813–25.
[5] Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem
2004;73:87–106.
[6] Rudel T, Kepp O, Kozjak-Pavlovic V. Interactions between bacterial pathogens
and mitochondrial cell death pathways. Nat Rev Microbiol 2010;8:693–705.
[7] Mileykovskaya E, Dowhan W. Cardiolipin membrane domains in prokaryotes
and eukaryotes. Biochim Biophys Acta 2009;1788:2084–91.
[8] Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from
proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010;11:655–67.
[9] Eisenreich W, Heesemann J, Rudel T, Goebel W. Metabolic host responses to
infection by intracellular bacterial pathogens. Front Cell Infect Microbiol
2013;3:24.
[10] Chan DC. Fusion and ﬁssion: interlinked processes critical for mitochondrial
health. Annu Rev Genet 2012;46:265–87.
[11] Campello S, Scorrano L. Mitochondrial shape changes: orchestrating cell
pathophysiology. EMBO Rep 2010;11:678–84.
[12] Yoshii SR, Kishi C, Ishihara N, Mizushima N. Parkin mediates proteasome-
dependent protein degradation and rupture of the outer mitochondrial
membrane. J Biol Chem 2011;286:19630–40.
[13] Govind R, Dupuy B. Secretion of Clostridium difﬁcile toxins A and B requires
the holin-like protein TcdE. PLoS Pathog 2012;8:e1002727.
[14] Giesemann T, Egerer M, Jank T, Aktories K. Processing of Clostridium difﬁcile
toxins. J Med Microbiol 2008;57:690–6.
[15] Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin
for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol 2012;2:92.
[16] Hayes CS, Aoki SK, Low DA. Bacterial contact-dependent delivery systems.
Annu Rev Genet 2010;44:71–90.
[17] Stavru F, Bouillaud F, Sartori A, Ricquier D, Cossart P. Listeria monocytogenes
transiently alters mitochondrial dynamics during infection. Proc Natl Acad
Sci U S A 2011;108:3612–7.
[18] Jiang JH, Davies JK, Lithgow T, Strugnell RA, Gabriel K. Targeting of Neisserial
PorB to the mitochondrial outer membrane: an insight on the evolution of
beta-barrel protein assembly machines. Mol Microbiol 2011;82:976–87.
[19] Papatheodorou P, Domanska G, Oxle M, Mathieu J, Selchow O, Kenny B, et al.
The enteropathogenic Escherichia coli (EPEC) map effector is imported into
the mitochondrial matrix by the TOM/Hsp70 system and alters organelle
morphology. Cell Microbiol 2006;8:677–89.
[20] Kenny B, Jepson M. Targeting of an enteropathogenic Escherichia coli (EPEC)
effector protein to host mitochondria. Cell Microbiol 2000;2:579–90.
[21] Lucattini R, Likic VA, Lithgow T. Bacterial proteins predisposed for targeting
to mitochondria. Mol Biol Evol 2004;21:652–8.
[22] Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev
Immunol 2014;32:609–34.
[23] Miller WL. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol
2013;379:62–73.
[24] Stehling O, Wilbrecht C, Lill R. Mitochondrial iron-sulfur protein biogenesis
and human disease. Biochimie 2014;100:61–77.
[25] Warburg O. On respiratory impairment in cancer cells. Science 1956;124:
269–70.
[26] Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg
effect: the metabolic requirements of cell proliferation. Science 2009;324:
1029–33.
[27] McGrath EE, Marriott HM, Lawrie A, Francis SE, Sabroe I, Renshaw SA, et al.
TNF-related apoptosis-inducing ligand (TRAIL) regulates inﬂammatory neu-
trophil apoptosis and enhances resolution of inﬂammation. J Leukoc Biol
2011;90:855–65.
[28] Everts B, Amiel E, Huang SC, Smith AM, Chang CH, Lam WY, et al. TLR-driven
early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports
the anabolic demands of dendritic cell activation. Nat Immunol 2014;15:
323–32.[29] Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, et al.
Epigenetic programming of monocyte-to-macrophage differentiation and
trained innate immunity. Science 2014;345:1251086.
[30] Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al.
mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for
trained immunity. Science 2014;345:1250684.
[31] Galvan-Pena S, O’Neill LA. Metabolic reprograming in macrophage polariza-
tion. Front Immunol 2014;5:420.
[32] Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF,
Goel G, et al. Succinate is an inﬂammatory signal that induces IL-1beta
through HIF-1alpha. Nature 2013;496:238–42.
[33] Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, et al. Oxidative
metabolism and PGC-1beta attenuate macrophage-mediated inﬂammation.
Cell Metab 2006;4:13–24.
[34] MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes.
Annu Rev Immunol 2013;31:259–83.
[35] Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, et al. The
CD28 signaling pathway regulates glucose metabolism. Immunity 2002;16:
769–77.
[36] Carr EL, Kelman A, Wu GS, Gopaul R, Senkevitch E, Aghvanyan A, et al.
Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK
during T lymphocyte activation. J Immunol 2010;185:1037–44.
[37] Chang CH, Curtis JD, Maggi Jr LB, Faubert B, Villarino AV, O’Sullivan D, et al.
Posttranscriptional control of T cell effector function by aerobic glycolysis.
Cell 2013;153:1239–51.
[38] Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, et al. Enhancing
CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009;460:
103–7.
[39] Pollizzi KN, Powell JD. Integrating canonical and metabolic signalling
programmes in the regulation of T cell responses. Nat Rev Immunol
2014;14:435–46.
[40] Dolezal P, Aili M, Tong J, Jiang JH, Marobbio CM, Lee SF, et al. Legionella
pneumophila secretes a mitochondrial carrier protein during infection. PLoS
Pathog 2012;8:e1002459.
[41] Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen
species. Mol Cell 2012;48:158–67.
[42] Mailloux RJ, Harper ME. Uncoupling proteins and the control of mitochondrial
reactive oxygen species production. Free Radic Biol Med 2011;51:1106–15.
[43] Emre Y, Nubel T. Uncoupling protein UCP2: when mitochondrial activity
meets immunity. FEBS Lett 2010;584:1437–42.
[44] Esteves TC, Brand MD. The reactions catalysed by the mitochondrial uncou-
pling proteins UCP2 and UCP3. Biochim Biophys Acta 2005;1709:35–44.
[45] Dikalov SI, Harrison DG. Methods for detection of mitochondrial and cellular
reactive oxygen species. Antioxid Redox Signal 2014;20:372–82.
[46] Sonoda J, Laganiere J, Mehl IR, Barish GD, Chong LW, Li X, et al. Nuclear
receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-
induced host defense. Genes Dev 2007;21:1909–20.
[47] West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P,
et al. TLR signalling augments macrophage bactericidal activity through
mitochondrial ROS. Nature 2011;472:476–80.
[48] Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, et al.
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity
and reactive oxygen species production. Nat Genet 2000;26:435–9.
[49] Mogensen TH. Pathogen recognition and inﬂammatory signaling in innate
immune defenses. Clin Microbiol Rev 2009;22:240–73. Table of Contents.
[50] Piantadosi CA, Suliman HB. Transcriptional control of mitochondrial biogen-
esis and its interface with inﬂammatory processes. Biochim Biophys Acta
2012;1820:532–41.
[51] Bauerfeld CP, Rastogi R, Pirockinaite G, Lee I, Huttemann M, Monks B, et al.
TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for
induction of oxidative phosphorylation and mitochondrial transcription
factor A in murine macrophages. J Immunol 2012;188:2847–57.
[52] Kim NH, Hong BK, Choi SY, Moo Kwon H, Cho CS, Yi EC, et al. Reactive oxygen
species regulate context-dependent inhibition of NFAT5 target genes. Exp
Mol Med 2013;45:e32.
[53] Jacobs JL, Coyne CB. Mechanisms of MAVS regulation at the mitochondrial
membrane. J Mol Biol 2013;425:5009–19.
[54] Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. Absence of autophagy
results in reactive oxygen species-dependent ampliﬁcation of RLR signaling.
Proc Natl Acad Sci U S A 2009;106:2770–5.
[55] Kondo T, Watanabe M, Hatakeyama S. TRIM59 interacts with ECSIT and
negatively regulates NF-kappaB and IRF-3/7-mediated signal pathways.
Biochem Biophys Res Commun 2012;422:501–7.
[56] Monroe KM, McWhirter SM, Vance RE. Identiﬁcation of host cytosolic sensors
and bacterial factors regulating the type I interferon response to Legionella
pneumophila. PLoS Pathog 2009;5:e1000665.
[57] Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al.
Autophagy proteins regulate innate immune responses by inhibiting the
release of mitochondrial DNA mediated by the NALP3 inﬂammasome. Nat
Immunol 2011;12:222–30.
[58] Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3
inﬂammasome activation. Nature 2011;469:221–5.
[59] Schroder K, Tschopp J. The inﬂammasomes. Cell 2010;140:821–32.
[60] Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. Non-
transcriptional priming and deubiquitination regulate NLRP3 inﬂammasome
activation. J Biol Chem 2012;287:36617–22.
E. Lobet et al. / Biochemical Pharmacology 94 (2015) 173–185184[61] Higa N, Toma C, Nohara T, Nakasone N, Takaesu G, Suzuki T. Lose the battle to
win the war: bacterial strategies for evading host inﬂammasome activation.
Trends Microbiol 2013;21:342–9.
[62] Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. The
adaptor MAVS promotes NLRP3 mitochondrial localization and inﬂamma-
some activation. Cell 2013;153:348–61.
[63] Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, et al. Microtubule-
driven spatial arrangement of mitochondria promotes activation of the
NLRP3 inﬂammasome. Nat Immunol 2013;14:454–60.
[64] Gomes MT, Campos PC, Oliveira FS, Corsetti PP, Bortoluci KR, Cunha LD, et al.
Critical role of ASC inﬂammasomes and bacterial type IV secretion system in
caspase-1 activation and host innate resistance to Brucella abortus infection. J
Immunol 2013;190:3629–38.
[65] Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, et al.
Caspase-1 dependent IL-1beta secretion is critical for host defense in a
mouse model of Chlamydia pneumoniae lung infection. PLoS ONE
2011;6:e21477.
[66] Taxman DJ, Huang MT, Ting JP. Inﬂammasome inhibition as a pathogenic
stealth mechanism. Cell Host Microbe 2010;8:7–11.
[67] Crane DD, Bauler TJ, Wehrly TD, Bosio CM. Mitochondrial ROS potentiates
indirect activation of the AIM2 inﬂammasome. Front Microbiol
2014;5:438.
[68] Hall CJ, Boyle RH, Astin JW, Flores MV, Oehlers SH, Sanderson LE, et al.
Immunoresponsive gene 1 augments bactericidal activity of macrophage-
lineage cells by regulating beta-oxidation-dependent mitochondrial ROS
production. Cell Metab 2013;18:265–78.
[69] Rousset S, Emre Y, Join-Lambert O, Hurtaud C, Ricquier D, Cassard-Doulcier
AM. The uncoupling protein 2 modulates the cytokine balance in innate
immunity. Cytokine 2006;35:135–42.
[70] Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, et al.
Mitochondria are required for antigen-speciﬁc T cell activation through
reactive oxygen species signaling. Immunity 2013;38:225–36.
[71] Rowlands DJ, Islam MN, Das SR, Huertas A, Quadri SK, Horiuchi K, et al.
Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines
the severity of inﬂammation in mouse lung microvessels. J Clin Invest
2011;121:1986–99.
[72] Cao T, Dong Y, Tang R, Chen J, Zhang CY, Zen K. Mitochondrial uncoupling
protein 2 protects splenocytes from oxidative stress-induced apoptosis
during pathogen activation. Cell Immunol 2013;286:39–44.
[73] Shin DM, Jeon BY, Lee HM, Jin HS, Yuk JM, Song CH, et al. Mycobacterium
tuberculosis eis regulates autophagy, inﬂammation, and cell death through
redox-dependent signaling. PLoS Pathog 2010;6:e1001230.
[74] Kim KH, An DR, Song J, Yoon JY, Kim HS, Yoon HJ, et al. Mycobacterium
tuberculosis Eis protein initiates suppression of host immune responses
by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A 2012;109:
7729–34.
[75] Roca FJ, Ramakrishnan L. TNF dually mediates resistance and susceptibility
to mycobacteria via mitochondrial reactive oxygen species. Cell 2013;153:
521–34.
[76] Abdul-Sater AA, Said-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, et al.
Enhancement of reactive oxygen species production and chlamydial infec-
tion by the mitochondrial Nod-like family member NLRX1. J Biol Chem
2010;285:41637–45.
[77] Itoh R, Murakami I, Chou B, Ishii K, Soejima T, Suzuki T, et al. Chlamydia
pneumoniae harness host NLRP3 inﬂammasome-mediated caspase-1 activa-
tion for optimal intracellular growth in murine macrophages. Biochem
Biophys Res Commun 2014;452:689–94.
[78] Strickertsson JA, Desler C, Rasmussen LJ. Impact of bacterial infections on
aging and cancer: impairment of DNA repair and mitochondrial function of
host cells. Exp Gerontol 2014;56:164–74.
[79] Huang XW, Luo RH, Zhao Q, Shen ZZ, Huang LL, An XY, et al. Helicobacter pylori
induces mitochondrial DNA mutation and reactive oxygen species level in
AGS cells. Int J Med Sci 2011;8:56–67.
[80] Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth
JW, Piantadosi CA. Toll-like receptor 4 mediates mitochondrial DNA
damage and biogenic responses after heat-inactivated E. coli. FASEB J
2005;19:1531–3.
[81] Kumar A, Wu H, Collier-Hyams LS, Kwon YM, Hanson JM, Neish AS. The
bacterial fermentation product butyrate inﬂuences epithelial signaling via
reactive oxygen species-mediated changes in cullin-1 neddylation. J Immu-
nol 2009;182:538–46.
[82] Macfabe DF. Short-chain fatty acid fermentation products of the gut micro-
biome: implications in autism spectrum disorders. Microb Ecol Health Dis
2012;23.
[83] Kaihami GH, Almeida JR, Santos SS, Netto LE, Almeida SR, Baldini RL. Involve-
ment of a 1-Cys peroxiredoxin in bacterial virulence. PLoS Pathog
2014;10:e1004442.
[84] Liu H, Bao W, Lin M, Niu H, Rikihisa Y. Ehrlichia type IV secretion effector
ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by
upregulating host MnSOD. Cell Microbiol 2012;14:1037–50.
[85] Clapham DE. Calcium signaling. Cell 2007;131:1047–58.
[86] Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors
and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012;13:566–78.
[87] De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. A forty-kilodalton
protein of the inner membrane is the mitochondrial calcium uniporter.
Nature 2011;476:336–40.[88] Brenner C, Moulin M. Physiological roles of the permeability transition pore.
Circ Res 2012;111:1237–47.
[89] Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and
ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004;287:
C817–33.
[90] McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation
of mammalian intramitochondrial metabolism. Physiol Rev 1990;70:391–
425.
[91] Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. Mitochondrial calcium and
the permeability transition in cell death. Biochim Biophys Acta 2009;1787:
1395–401.
[92] Carrithers LM, Hulseberg P, Sandor M, Carrithers MD. The human macro-
phage sodium channel NaV1.5 regulates mycobacteria processing through
organelle polarization and localized calcium oscillations. FEMS Immunol
Med Microbiol 2011;63:319–27.
[93] Liu DQ, Guo YL, Bian Z, Chen YY, Chen X, Liu Y, et al. Uncoupling protein-2
negatively regulates polymorphonuclear leukocytes chemotaxis via modu-
lating [Ca2+] inﬂux. Arterioscler Thromb Vasc Biol 2010;30:575–81.
[94] Bonifaz L, Cervantes-Silva M, Ontiveros-Dotor E, Lopez-Villegas E, Sanchez-
Garcia F. A role for mitochondria in antigen processing and presentation.
Immunology 2014;144(3):461–71. March 2015.
[95] Quintana A, Hoth M. Mitochondrial dynamics and their impact on T cell
function. Cell Calcium 2012;52:57–63.
[96] Ledderose C, Bao Y, Lidicky M, Zipperle J, Li L, Strasser K, et al. Mitochondria
are gate-keepers of T cell function by producing the ATP that drives pur-
inergic signaling. J Biol Chem 2014;289:25936–45.
[97] Czyz DM, Potluri LP, Jain-Gupta N, Riley SP, Martinez JJ, Steck TL, et al. Host-
directed antimicrobial drugs with broad-spectrum efﬁcacy against intracel-
lular bacterial pathogens. mBio 2014;5:e01534–1614.
[98] Cywes Bentley C, Hakansson A, Christianson J, Wessels MR. Extracellular
group A Streptococcus induces keratinocyte apoptosis by dysregulating
calcium signalling. Cell Microbiol 2005;7:945–55.
[99] Seo JH, Fox JG, Peek Jr RM, Hagen SJ. N-methyl D-aspartate channels link
ammonia and epithelial cell death mechanisms in Helicobacter pylori infec-
tion. Gastroenterology 2011;141:2064–75.
[100] Kennedy CL, Smith DJ, Lyras D, Chakravorty A, Rood JI. Programmed cellular
necrosis mediated by the pore-forming alpha-toxin from Clostridium septi-
cum. PLoS Pathog 2009;5:e1000516.
[101] Matarrese P, Falzano L, Fabbri A, Gambardella L, Frank C, Geny B, et al.
Clostridium difﬁcile toxin B causes apoptosis in epithelial cells by thrilling
mitochondria. Involvement of ATP-sensitive mitochondrial potassium chan-
nels. J Biol Chem 2007;282:9029–41.
[102] Kim JM, Kim JS, Lee JY, Kim YJ, Youn HJ, Kim IY, et al. Vacuolating cytotoxin
in Helicobacter pylori water-soluble proteins upregulates chemokine ex-
pression in human eosinophils via Ca2+ inﬂux, mitochondrial reactive
oxygen intermediates, and NF-kappaB activation. Infect Immun 2007;75:
3373–81.
[103] Tran Van Nhieu G, Kai Liu B, Zhang J, Pierre F, Prigent S, Sansonetti P, et al.
Actin-based conﬁnement of calcium responses during Shigella invasion. Nat
Commun 2013;4:1567.
[104] Hong EE, Okitsu CY, Smith AD, Hsieh CL. Regionally speciﬁc and genome-
wide analyses conclusively demonstrate the absence of CpG methylation in
human mitochondrial DNA. Mol Cell Biol 2013;33:2683–90.
[105] Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating
mitochondrial DAMPs cause inﬂammatory responses to injury. Nature
2010;464:104–7.
[106] Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously
oxidized mitochondrial DNA induces in vivo and in vitro inﬂammatory
responses. J Leukoc Biol 2004;75:995–1000.
[107] Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, et al.
Toll-like receptor 9 protects non-immune cells from stress by modulating
mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep
2014;15:438–45.
[108] de Bernard M, Rizzuto R. Toll-like receptors hit calcium. EMBO Rep
2014;15:468–9.
[109] Tait SW, Green DR. Mitochondria and cell signalling. J Cell Sci 2012;125:807–15.
[110] Raoof M, Zhang Q, Itagaki K, Hauser CJ. Mitochondrial peptides are potent
immune activators that activate human neutrophils via FPR-1. J Trauma
2010;68:1328–32. discussion 32–4.
[111] Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et al. Mitochondrial DAMPs
increase endothelial permeability through neutrophil dependent and inde-
pendent pathways. PLOS ONE 2013;8:e59989.
[112] Crouser ED, Shao G, Julian MW, Macre JE, Shadel GS, Tridandapani S, et al.
Monocyte activation by necrotic cells is promoted by mitochondrial proteins
and formyl peptide receptors. Crit Care Med 2009;37:2000–9.
[113] Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a
putative endogenous ligand of the toll-like receptor-4 complex. J Immunol
2000;164:558–61.
[114] Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, et al. Inﬂamma-
tory response after open heart surgery: release of heat-shock protein
70 and signaling through toll-like receptor-4. Circulation 2002;105:
685–90.
[115] Nicholas SA, Coughlan K, Yasinska I, Lall GS, Gibbs BF, Calzolai L, et al.
Dysfunctional mitochondria contain endogenous high-afﬁnity human Toll-
like receptor 4 (TLR4) ligands and induce TLR4-mediated inﬂammatory
reactions. Int J Biochem Cell Biol 2011;43:674–81.
E. Lobet et al. / Biochemical Pharmacology 94 (2015) 173–185 185[116] Schwacha MG, Rani M, Zhang Q, Nunez-Cantu O, Cap AP. Mitochondrial
damage-associated molecular patterns activate gammadelta T-cells. Innate
Immun 2014;20:261–8.
[117] Stavru F, Palmer AE, Wang C, Youle RJ, Cossart P. Atypical mitochondrial
ﬁssion upon bacterial infection. Proc Natl Acad Sci U S A 2013;110:16003–08.
[118] Jain P, Luo ZQ, Blanke SR. Helicobacter pylori vacuolating cytotoxin A (VacA)
engages the mitochondrial ﬁssion machinery to induce host cell death. Proc
Natl Acad Sci U S A 2011;108:16032–37.[119] Suzuki M, Danilchanka O, Mekalanos JJ. Vibrio cholerae T3SS effector VopE
modulates mitochondrial dynamics and innate immune signaling by target-
ing Miro GTPases. Cell Host Microbe 2014;16:581–91.
[120] Tattoli I, Carneiro LA, Jehanno M, Magalhaes JG, Shu Y, Philpott DJ, et al.
NLRX1 is a mitochondrial NOD-like receptor that ampliﬁes NF-kappaB and
JNK pathways by inducing reactive oxygen species production. EMBO Rep
2008;9:293–300.
